We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Partnerships with local start-ups hit record despite data security and IP protection concerns
Kuehne+Nagel says production capacity is main limitation to supply of Covid-19 shots
Survey findings released as concerns intensify over uneven distribution of vaccines
Oxford Biomedica plans to use earnings from AstraZeneca jab to boost own medicines business
Move is part of bloc’s effort to boost faltering immunisation programme
Canberra urges Brussels to review Rome’s move while also expressing sympathy to EU
Recommendations from two FT roundtables with pharma, government, and NGO experts
U-turn could help speed up the country’s sluggish Covid-19 vaccination campaign
Intervention threatens to increase global tensions over procurement of Covid jabs
Decision makes approval possible in as little as two weeks after final data is received from manufacturers
White House announces accelerated timeline after brokering production deal between J&J and Merck
Surveillance of AstraZeneca and Pfizer recipients in UK reports minor complaints but few severe reactions
UK research into LSD consumption reveals expectation of improved wellbeing drives transformation
Green energy supplier takes top spot and London remains the city with the most high-growth businesses
New data bring about policy shift as other EU countries likely to abandon age limits
News about P.1 variant balanced by data confirming vaccines highly effective at preventing disease
EU jab strategy under strain amid growing anxiety over bloc’s slow inoculation drive
US company prepares to launch its vaccine but the road to success has been long
Budapest also orders Russia-made shot despite lack of approval for use within bloc
Similar move expected in France as EU governments come under pressure to clear stockpile of unused vaccines
International travel restrictions expected until next year
Regulator gives emergency approval to third Covid treatment and first involving a single shot
Single-shot jab is third Covid treatment to be authorised in country
Vote by independent experts paves the way for first single-dose jab in the US
Approach seeks to cut years off traditional licensing process for treatments
International Edition
